Structural analysis of autoinhibition in the Ras-specific exchange factor RasGRP1

eLife

Volumn 2013, Issue 2, 2013, Pages

  Iwig, Jeffrey S ^a,b   Vercoulen, Yvonne ^c   Das, Rahul ^a,b   Barros, Tiago ^a,b   Limnander, Andre ^c   Che, Yan ^a,b   Pelton, Jeffrey G ^b   Wemmer, David E ^a,b,d   Roose, Jeroen P ^c   Kuriyan, John ^a,b,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALMODULIN; DIACYLGLYCEROL; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLSERINE; PROTEIN RASGRP1; PROTEIN TYROSINE PHOSPHATASE; RAS PROTEIN; UNCLASSIFIED DRUG; CALCIUM; DNA BINDING PROTEIN; GUANINE NUCLEOTIDE EXCHANGE FACTOR; RASGRP1 PROTEIN, HUMAN; RECOMBINANT PROTEIN;

ARTICLE; BINDING SITE; CALCIUM BINDING; CIRCULAR DICHROISM; CONFORMATIONAL TRANSITION; CRYSTAL STRUCTURE; CRYSTALLIZATION; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; GENE MUTATION; HUMAN; HUMAN CELL; NITROGEN NUCLEAR MAGNETIC RESONANCE; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; NUCLEAR OVERHAUSER EFFECT; PROTEIN EXPRESSION; PROTON NUCLEAR MAGNETIC RESONANCE; SEQUENCE ALIGNMENT; STRUCTURE ANALYSIS; AMINO ACID SEQUENCE; ANTAGONISTS AND INHIBITORS; CHEMICAL STRUCTURE; CHEMISTRY; METABOLISM; MOLECULAR GENETICS; NUCLEAR MAGNETIC RESONANCE; PROTEIN CONFORMATION; SEQUENCE HOMOLOGY; X RAY CRYSTALLOGRAPHY;

AMINO ACID SEQUENCE; BINDING SITES; CALCIUM; CRYSTALLOGRAPHY, X-RAY; DNA-BINDING PROTEINS; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PROTEIN CONFORMATION; RECOMBINANT PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 84881045879     PISSN: None     EISSN: 2050084X     Source Type: Journal    
DOI: 10.7554/eLife.00813     Document Type: Article

References (105)

1. Adams PD, Afonine PV, Bunkoczi G, Chen VB, Davis IW, Echols N, et al. 2010. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr D Biol Crystallogr 66:213-21. doi: 10.1107/S0907444909052925.
2. Ahearn IM, Haigis K, Bar-Sagi D, Philips MR. 2012. Regulating the regulator: post-translational modification of RAS. Nat Rev Mol Cell Biol 13:39-51. doi: 10.1038/nrm3255.
3. Ahmadian MR, Wittinghofer A, Herrmann C. 2002. Fluorescence methods in the study of small GTP-binding proteins. Methods Mol Biol 189:45-63. doi: 10.1385/1-59259-281-3:045.
4. Aiba Y, Oh-hora M, Kiyonaka S, Kimura Y, Hijikata A, Mori Y, et al. 2004. Activation of RasGRP3 by phosphorylation of Thr-133 is required for B cell receptor-mediated Ras activation. Proc Natl Acad Sci USA 101:16612-7. doi: 10.1073/pnas.0407468101.
5. Akagi K, Suzuki T, Stephens RM, Jenkins NA, Copeland NG. 2004. RTCGD: retroviral tagged cancer gene database. Nucleic Acids Res 32:D523-527. doi: 10.1093/nar/gkh013.
6. Ames JB, Dizhoor AM, Ikura M, Palczewski K, Stryer L. 1999. Three-dimensional structure of guanylyl cyclase activating protein-2, a calcium-sensitive modulator of photoreceptor guanylyl cyclases. J Biol Chem 274:19329-37. doi: 10.1074/jbc.274.27.19329.
7. Aravind P, Chandra K, Reddy PP, Jeromin A, Chary KV, Sharma Y. 2008. Regulatory and structural EF-hand motifs of neuronal calcium sensor-1: mg 2+ modulates Ca 2+ binding, Ca 2+ -induced conformational changes, and equilibrium unfolding transitions. J Mol Biol 376:1100-15. doi: 10.1016/j.jmb.2007.12.033.
8. Aronheim A, Engelberg D, Li N, al-Alawi N, Schlessinger J, Karin M. 1994. Membrane targeting of the nucleotide exchange factor Sos is sufficient for activating the Ras signaling pathway. Cell 78:949-61. doi: 10.1016/0092-8674(94)90271-2.
9. Beaulieu N, Zahedi B, Goulding RE, Tazmini G, Anthony KV, Omeis SL, et al. 2007. Regulation of RasGRP1 by B cell antigen receptor requires cooperativity between three domains controlling translocation to the plasma membrane. Mol Biol Cell. 18:3156-68. doi: 10.1091/mbc.E06-10-0932.
10. Berjanskii MV, Neal S, Wishart DS. 2006. PREDITOR: a web server for predicting protein torsion angle restraints. Nucleic Acids Res 34:W63-69. doi: 10.1093/nar/gkl341.
11. Bhattacharya A, Tejero R, Montelione GT. 2007. Evaluating protein structures determined by structural genomics consortia. Proteins 66:778-95. doi: 10.1002/prot.21165.
12. Boriack-Sjodin PA, Margarit SM, Bar-Sagi D, Kuriyan J. 1998. The structural basis of the activation of Ras by Sos. Nature 394:337-43. doi: 10.1038/28548.
13. Bos JL, Rehmann H, Wittinghofer A. 2007. GEFs and GAPs: critical elements in the control of small G proteins. Cell 129:865-77. doi: 10.1016/j.cell.2007.05.018.
14. Boykevisch S, Zhao C, Sondermann H, Philippidou P, Halegoua S, Kuriyan J, et al. 2006. Regulation of ras signaling dynamics by Sos-mediated positive feedback. Current biology 16:2173-9. doi: 10.1016/j.cub.2006.09.033.
15. Brodie C, Steinhart R, Kazimirsky G, Rubinfeld H, Hyman T, Ayres JN, et al. 2004. PKCdelta associates with and is involved in the phosphorylation of RasGRP3 in response to phorbol esters. Mol Pharmacol 66:76-84. doi: 10.1124/mol.66.1.76.
16. Brunger AT. 2007. Version 1.2 of the crystallography and NMR system. Nat Protoc 2:2728-33. doi: 10.1038/nprot.2007.406.
17. Canagarajah B, Leskow FC, Ho JY, Mischak H, Saidi LF, Kazanietz MG, et al. 2004. Structural mechanism for lipid activation of the Rac-specific GAP, beta2-chimaerin. Cell 119:407-18. doi: 10.1016/j.cell.2004.10.012.
18. Cherfils J, Zeghouf M. 2013. Regulation of small GTPases by GEFs, GAPs, and GDIs. Physiol Rev 93:269-309. doi: 10.1152/physrev.00003.2012.
19. Clore GM, Gronenborn AM, Bax A. 1998. A robust method for determining the magnitude of the fully asymmetric alignment tensor of oriented macromolecules in the absence of structural information. J Magn Reson 133:216-21. doi: 10.1006/jmre.1998.1419.
20. Coughlin JJ, Stang SL, Dower NA, Stone JC. 2005. RasGRP1 and RasGRP3 regulate B cell proliferation by facilitating B cell receptor-Ras signaling. J Immunol 175:7179-84.
21. Daniels MA, Teixeiro E, Gill J, Hausmann B, Roubaty D, Holmberg K, et al. 2006. Thymic selection threshold defined by compartmentalization of Ras/MAPK signalling. Nature 444:724-9. doi: 10.1038/nature05269.
22. Das J, Ho M, Zikherman J, Govern C, Yang M, Weiss A, et al. 2009. Digital signaling and hysteresis characterize ras activation in lymphoid cells. Cell 136:337-51. doi: 10.1016/j.cell.2008.11.051.
23. Day CL, Alber T. 2000. Crystal structure of the amino-terminal coiled-coil domain of the APC tumor suppressor. J Mol Biol 301:147-56. doi: 10.1006/jmbi.2000.3895.
24. Delaglio F, Grzesiek S, Vuister GW, Zhu G, Pfeifer J, Bax A. 1995. NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J Biomol NMR 6:277-93. doi: 10.1007/BF00197809.
25. Diez FR, Garrido AA, Sharma A, Luke CT, Stone JC, Dower NA, et al. 2009. RasGRP1 transgenic mice develop cutaneous squamous cell carcinomas in response to skin wounding: potential role of granulocyte colony-stimulating factor. Am J Pathol 175:392-9. doi: 10.2353/ajpath.2009.090036.
26. DiNitto JP, Delprato A, Gabe Lee MT, Cronin TC, Huang S, Guilherme A, et al. 2007. Structural basis and mechanism of autoregulation in 3-phosphoinositide-dependent Grp1 family Arf GTPase exchange factors. Mol Cell 28:569-83. doi: 10.1016/j.molcel.2007.09.017.
27. Dower NA, Stang SL, Bottorff DA, Ebinu JO, Dickie P, Ostergaard HL, et al. 2000. RasGRP is essential for mouse thymocyte differentiation and TCR signaling. Nat Immunol 1:317-21. doi: 10.1038/79766.
28. Ebinu JO, Bottorff DA, Chan EY, Stang SL, Dunn RJ, Stone JC. 1998. RasGRP, a Ras guanyl nucleotidereleasing protein with calcium- and diacylglycerol-binding motifs. Science 280:1082-6. doi: 10.1126/science.280.5366.1082.
29. Ebinu JO, Stang SL, Teixeira C, Bottorff DA, Hooton J, Blumberg PM, et al. 2000. RasGRP links T-cell receptor signaling to Ras. Blood 95:3199-203.
30. Findlay GM, Smith MJ, Lanner F, Hsiung MS, Gish GD, Petsalaki E, et al. 2013. Interaction domains of sos1/grb2 are finely tuned for cooperative control of embryonic stem cell fate. Cell 152:1008-20. doi: 10.1016/j.cell.2013.01.056.
31. Freedman TS, Sondermann H, Friedland GD, Kortemme T, Bar-Sagi D, Marqusee S, et al. 2006. A Ras-induced conformational switch in the Ras activator Son of sevenless. Proc Natl Acad Sci USA 103:16692-7. doi: 10.1073/pnas.0608127103.
32. Fuller DM, Zhu M, Song X, Ou-Yang CW, Sullivan SA, Stone JC, et al. 2012. Regulation of RasGRP1 function in T cell development and activation by its unique tail domain. PloS One 7:e38796. doi: 10.1371/journal.pone.0038796.
33. Gifford JL, Walsh MP, Vogel HJ. 2007. Structures and metal-ion-binding properties of the Ca2+-binding helix-loop-helix EF-hand motifs. Biochem J 405:199-221. doi: 10.1042/BJ20070255.
34. Golec DP, Dower NA, Stone JC, Baldwin TA. 2013. RasGRP1, but not RasGRP3, is required for efficient thymic beta-selection and ERK activation downstream of CXCR4. PloS One 8:e53300. doi: 10.1371/journal.pone.0053300.
35. Grzesiek S, Anglister J, Bax A. 1993. Correlation of backbone amide and aliphatic side-chain resonances in 13C/15N-enriched proteins by isotropic mixing of 13C magnetization. J Magn Reson B 101:114-9. doi: 10.1006/jmrb.1993.1019.
36. Guntert P, Billeter M, Ohlenschlager O, Brown LR, Wuthrich K. 1998. Conformational analysis of protein and nucleic acid fragments with the new grid search algorithm FOUND. J Biomol NMR 12:543-8. doi: 10.1023/A:1008391403193.
37. Gureasko J, Galush WJ, Boykevisch S, Sondermann H, Bar-Sagi D, Groves JT, et al. 2008. Membrane-dependent signal integration by the Ras activator Son of sevenless. Nat Struct Mol Biol 15:452-61. doi: 10.1038/nsmb.1418.
38. Gureasko J, Kuchment O, Makino DL, Sondermann H, Bar-Sagi D, Kuriyan J. 2010. Role of the histone domain in the autoinhibition and activation of the Ras activator Son of Sevenless. Proc Natl Acad Sci USA 107:3430-5. doi: 10.1073/pnas.0913915107.
39. Hall BE, Yang SS, Boriack-Sjodin PA, Kuriyan J, Bar-Sagi D. 2001. Structure-based mutagenesis reveals distinct functions for Ras switch 1 and switch 2 in Sos-catalyzed guanine nucleotide exchange. J Biol Chem 276:27629-37. doi: 10.1074/jbc.M101727200.
40. Hansen MR, Mueller L, Pardi A. 1998. Tunable alignment of macromolecules by filamentous phage yields dipolar coupling interactions. Nat Struct Biol 5:1065-74. doi: 10.1038/4176.
41. Hartzell C, Ksionda O, Lemmens E, Coakley K, Yang M, Dail M, et al. 2013. Dysregulated RasGRP1 responds to cytokine receptor input in T cell leukemogenesis. Sci Signal 6:ra21. doi: 10.1126/scisignal.2003848.
42. Hurley JH, Newton AC, Parker PJ, Blumberg PM, Nishizuka Y. 1997. Taxonomy and function of C1 protein kinase C homology domains. Protein Sci 6:477-80. doi: 10.1002/pro.5560060228.
43. Ikura M, Minowa O, Hikichi K. 1985. Hydrogen bonding in the carboxyl-terminal half-fragment 78-148 of calmodulin as studied by two-dimensional nuclear magnetic resonance. Biochemistry 24:4264-9. doi: 10.1021/bi00337a002.
44. Kabsch W. 2010. XDS. Acta Crystallogr D Biol Crystallogr 66:125-32. doi: 10.1107/S0907444909047337.
45. Kay LE, Ikura M, Tschudin R, Bax A. 2011. Three-dimensional triple-resonance NMR spectroscopy of isotopically enriched proteins. 1990. J Magn Reson 213:423-41. doi: 10.1016/j.jmr.2011.09.004.
46. Klinger MB, Guilbault B, Goulding RE, Kay RJ. 2005. Deregulated expression of RasGRP1 initiates thymic lymphomagenesis independently of T-cell receptors. Oncogene 24:2695-704. doi: 10.1038/sj.onc.1208334.
47. Kortum RL, Sommers CL, Alexander CP, Pinski JM, Li W, Grinberg A, et al. 2011. Targeted Sos1 deletion reveals its critical role in early T-cell development. Proc Natl Acad Sci USA 108:12407-12. doi: 10.1073/pnas.1104295108.
48. Kortum RL, Sommers CL, Pinski JM, Alexander CP, Merrill RK, Li W, et al. 2012. Deconstructing Ras signaling in the thymus. Mol Cell Biol 32:2748-59. doi: 10.1128/MCB.00317-12.
49. Krutzik PO, Nolan GP. 2006. Fluorescent cell barcoding in flow cytometry allows high-throughput drug screening and signaling profiling. Nat Methods 3:361-8. doi: 10.1038/nmeth872.
50. Laskowski RA, Rullmannn JA, MacArthur MW, Kaptein R, Thornton JM. 1996. AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR. J Biomol NMR 8:477-86. doi: 10.1007/BF00228148.
51. Lauchle JO, Kim D, Le DT, Akagi K, Crone M, Krisman K, et al. 2009. Response and resistance to MEK inhibition in leukaemias initiated by hyperactive Ras. Nature 461:411-4. doi: 10.1038/nature08279.
52. Layer K, Lin G, Nencioni A, Hu W, Schmucker A, Antov AN, et al. 2003. Autoimmunity as the consequence of a spontaneous mutation in Rasgrp1. Immunity 19:243-55. doi: 10.1016/S1074-7613(03)00209-7.
53. Le Clainche L, Plancque G, Amekraz B, Moulin C, Pradines-Lecomte C, Peltier G, et al. 2003. Engineering new metal specificity in EF-hand peptides. J Biol Inorg Chem 8:334-40. doi: 10.1007/s00775-002-0419-2.
54. Leonard TA, Rozycki B, Saidi LF, Hummer G, Hurley JH. 2011. Crystal structure and allosteric activation of protein kinase C betaII. Cell 144:55-66. doi: 10.1016/j.cell.2010.12.013.
55. Limnander A, Depeille P, Freedman TS, Liou J, Leitges M, Kurosaki T, et al. 2011. STIM1, PKC-δ and RasGRP set a threshold for proapoptotic Erk signaling during B cell development. Nat Immunol 12:425-33. doi: 10.1038/ni.2016.
56. Lorenzo PS, Beheshti M, Pettit GR, Stone JC, Blumberg PM. 2000. The guanine nucleotide exchange factor RasGRP is a high-affinity target for diacylglycerol and phorbol esters. Mol Pharmacol 57:840-6.
57. Luke CT, Oki-Idouchi CE, Cline JM, Lorenzo PS. 2007. RasGRP1 overexpression in the epidermis of transgenic mice contributes to tumor progression during multistage skin carcinogenesis. Cancer Res 67:10190-7. doi: 10.1158/0008-5472.CAN-07-2375.
58. Lupas A, Van Dyke M, Stock J. 1991. Predicting coiled coils from protein sequences. Science 252:1162-4. doi: 10.1126/science.252.5009.1162.
59. Margarit SM, Sondermann H, Hall BE, Nagar B, Hoelz A, Pirruccello M, et al. 2003. Structural evidence for feedback activation by Ras.GTP of the Ras-specific nucleotide exchange factor SOS. Cell 112:685-95. doi: 10.1016/S0092-8674(03)00149-1.
60. McCoy AJ, Grosse-Kunstleve RW, Adams PD, Winn MD, Storoni LC, Read RJ. 2007. Phaser crystallographic software. J Appl Crystallogr 40:658-74. doi: 10.1107/S0021889807021206.
61. Mikkers H, Allen J, Knipscheer P, Romeijn L, Hart A, Vink E, et al. 2002. High-throughput retroviral tagging to identify components of specific signaling pathways in cancer. Nat Genet 32:153-9. doi: 10.1038/ng950.
62. Oki T, Kitaura J, Watanabe-Okochi N, Nishimura K, Maehara A, Uchida T, et al. 2012. Aberrant expression of RasGRP1 cooperates with gain-of-function NOTCH1 mutations in T-cell leukemogenesis. Leukemia 26:1038-45. doi: 10.1038/leu.2011.328.
63. Oki-Idouchi CE, Lorenzo PS. 2007. Transgenic overexpression of RasGRP1 in mouse epidermis results in spontaneous tumors of the skin. Cancer Res 67:276-80. doi: 10.1158/0008-5472.CAN-06-3080.
64. O'Shea EK, Klemm JD, Kim PS, Alber T. 1991. X-ray structure of the GCN4 leucine zipper, a two-stranded, parallel coiled coil. Science 254:539-44. doi: 10.1126/science.1948029.
65. Ottiger M, Delaglio F, Bax A. 1998. Measurement of J and dipolar couplings from simplified two-dimensional NMR spectra. J Magn Reson 131:373-8. doi: 10.1006/jmre.1998.1361.
66. Pan W, Zhu S, Yuan M, Cui H, Wang L, Luo X, et al. 2010. MicroRNA-21 and microRNA-148a contribute to DNA hypomethylation in lupus CD4+ T cells by directly and indirectly targeting DNA methyltransferase 1. J Immunol 184:6773-81. doi: 10.4049/jimmunol.0904060.
67. Petri ET, Celic A, Kennedy SD, Ehrlich BE, Boggon TJ, Hodsdon ME. 2010. Structure of the EF-hand domain of polycystin-2 suggests a mechanism for Ca2+-dependent regulation of polycystin-2 channel activity. Proc Natl Acad Sci USA 107:9176-81. doi: 10.1073/pnas.0912295107.
68. Plagnol V, Howson JM, Smyth DJ, Walker N, Hafler JP, Wallace C, et al. 2011. Genome-wide association analysis of autoantibody positivity in type 1 diabetes cases. PLoS Genet 7:e1002216. doi: 10.1371/journal.pgen.1002216.
69. Prasad A, Zikherman J, Das J, Roose JP, Weiss A, Chakraborty AK. 2009. Origin of the sharp boundary that discriminates positive and negative selection of thymocytes. Proc Natl Acad Sci USA 106:528-33. doi: 10.1073/pnas.0805981105.
70. Praznikar J, Afonine PV, Guncar G, Adams PD, Turk D. 2009. Averaged kick maps: less noise, more signal... and probably less bias. Acta Crystallogr D Biol Crystallogr 65:921-31. doi: 10.1107/S0907444909021933.
71. Qu HQ, Grant SF, Bradfield JP, Kim C, Frackelton E, Hakonarson H, et al. 2009. Association of RASGRP1 with type 1 diabetes is revealed by combined follow-up of two genome-wide studies. J Med Genet 46:553-4. doi: 10.1136/jmg.2009.067140.
72. Rajalingam K, Schreck R, Rapp UR, Albert S. 2007. Ras oncogenes and their downstream targets. Biochimica et biophysica acta 1773:1177-95. doi: 10.1016/j.bbamcr.2007.01.012.
73. Rehmann H, Das J, Knipscheer P, Wittinghofer A, Bos JL. 2006. Structure of the cyclic-AMP-responsive exchange factor Epac2 in its auto-inhibited state. Nature 439:625-8. doi: 10.1038/nature04468.
74. Rehmann H, Arias-Palomo E, Hadders MA, Schwede F, Llorca O, Bos JL. 2008. Structure of Epac2 in complex with a cyclic AMP analogue and RAP1B. Nature 455:124-7. doi: 10.1038/nature07187.
75. Reuther GW, Lambert QT, Rebhun JF, Caligiuri MA, Quilliam LA, Der CJ. 2002. RasGRP4 is a novel Ras activator isolated from acute myeloid leukemia. J Biol Chem 277:30508-14. doi: 10.1074/jbc.M111330200.
76. Roberts AE, Araki T, Swanson KD, Montgomery KT, Schiripo TA, Joshi VA, et al. 2007. Germline gain-of-function mutations in SOS1 cause Noonan syndrome. Nat Genet 39:70-4. doi: 10.1038/ng1926.
77. Roose JP, Mollenauer M, Gupta VA, Stone J, Weiss A. 2005. A diacylglycerol-protein kinase C-RasGRP1 pathway directs Ras activation upon antigen receptor stimulation of T cells. Mol Cell Biol 25:4426-41. doi: 10.1128/MCB.25.11.4426-4441.2005.
78. Roose JP, Mollenauer M, Ho M, Kurosaki T, Weiss A. 2007. Unusual interplay of two types of Ras activators, RasGRP and SOS, establishes sensitive and robust Ras activation in lymphocytes. Mol Cell Biol 27:2732-45. doi: 10.1128/MCB.01882-06.
79. 2+ buffers. Cold Spring Harb Perspect Biol 2:a004051. doi: 10.1101/cshperspect.a004051.
80. Shen Y, Delaglio F, Cornilescu G, Bax A. 2009. TALOS+: a hybrid method for predicting protein backbone torsion angles from NMR chemical shifts. J Biomol NMR 44:213-23. doi: 10.1007/s10858-009-9333-z.
81. Sondermann H, Soisson SM, Boykevisch S, Yang SS, Bar-Sagi D, Kuriyan J. 2004. Structural analysis of autoinhibition in the Ras activator Son of sevenless. Cell 119:393-405. doi: 10.1016/j.cell.2004.10.005.
82. Starr TK, Jameson SC, Hogquist KA. 2003. Positive and negative selection of T cells. Annu Rev Immunol 21:139-76. doi: 10.1146/annurev.immunol.21.120601.141107.
83. Stone JC. 2011. Regulation and function of the RasGRP family of ras activators in blood cells. Genes Cancer 2:320-34. doi: 10.1177/1947601911408082.
84. Suzuki T, Shen H, Akagi K, Morse HC, Malley JD, Naiman DQ, et al. 2002. New genes involved in cancer identified by retroviral tagging. Nat Genet 32:166-74. doi: 10.1038/ng949.
85. Swan KA, Alberola-Ila J, Gross JA, Appleby MW, Forbush KA, Thomas JF, et al. 1995. Involvement of p21ras distinguishes positive and negative selection in thymocytes. EMBO J 14:276-85.
86. Tartaglia M, Pennacchio LA, Zhao C, Yadav KK, Fodale V, Sarkozy A, et al. 2007. Gain-of-function SOS1 mutations cause a distinctive form of Noonan syndrome. Nat Genet 39:75-9. doi: 10.1038/ng1939.
87. Tazmini G, Beaulieu N, Woo A, Zahedi B, Goulding RE, Kay RJ. 2009. Membrane localization of RasGRP1 is controlled by an EF-hand, and by the GEF domain. Biochimica et biophysica acta 1793:447-61. doi: 10.1016/j.bbamcr.2008.12.019.
88. Usachev YM, Marchenko SM, Sage SO. 1995. Cytosolic calcium concentration in resting and stimulated endothelium of excised intact rat aorta. J Physiol 489:309-17.
89. Veeraraghavan S, Fagan PA, Hu H, Lee V, Harper JF, Huang B, et al. 2002. Structural independence of the two EF-hand domains of caltractin. J Biol Chem 277:28564-71. doi: 10.1074/jbc.M112232200.
90. Vetter IR, Wittinghofer A. 2001. The guanine nucleotide-binding switch in three dimensions. Science 294:1299-304. doi: 10.1126/science.1062023.
91. Wang W, Fisher EM, Jia Q, Dunn JM, Porfiri E, Downward J, et al. 1995. The Grb2 binding domain of mSos1 is not required for downstream signal transduction. Nat Genet 10:294-300. doi: 10.1038/ng0795-294.
92. Winn MD, Ballard CC, Cowtan KD, Dodson EJ, Emsley P, Evans PR, et al. 2011. Overview of the CCP4 suite and current developments. Acta Crystallogr D Biol Crystallogr 67:235-42. doi: 10.1107/S0907444910045749.
93. Wishart DS, Bigam CG, Yao J, Abildgaard F, Dyson HJ, Oldfield E, et al. 1995. 1H, 13C and 15N chemical shift referencing in biomolecular NMR. J Biomol NMR 6:135-40. doi: 10.1007/BF00211777.
94. Yang D, Kedei N, Li L, Tao J, Velasquez JF, Michalowski AM, et al. 2010. RasGRP3 contributes to formation and maintenance of the prostate cancer phenotype. Cancer Res 70:7905-17. doi: 10.1158/0008-5472.CAN-09-4729.
95. Yang D, Tao J, Li L, Kedei N, Toth ZE, Czap A, et al. 2011. RasGRP3, a Ras activator, contributes to signaling and the tumorigenic phenotype in human melanoma. Oncogene 30:4590-600. doi: 10.1038/onc.2011.166.
96. Yang D, Tolman JR, Goto NK, Kay LE. 1998. An HNCO-based pulse scheme for the measurement of 13Calpha-1Halpha one-bond dipolar couplings in 15N, 13C labeled proteins. J Biomol NMR 12:325-32. doi: 10.1023/A:1008223017233.
97. Goddard TD, Kneller DG. SPARKY 3. San Francisco, University of California.
98. Yang W, Jones LM, Isley L, Ye Y, Lee HW, Wilkins A, et al. 2003. Rational design of a calcium-binding protein. J Am Chem Soc 125:6165-71. doi: 10.1021/ja034724x.
99. Yang Y, Li L, Wong GW, Krilis SA, Madhusudhan MS, Sali A, et al. 2002. RasGRP4, a new mast cell-restricted Ras guanine nucleotide-releasing protein with calcium- and diacylglycerol-binding motifs. Identification of defective variants of this signaling protein in asthma, mastocytosis, and mast cell leukemia patients and demonstration of the importance of RasGRP4 in mast cell development and function. J Biol Chem 277:25756-74. doi: 10.1074/jbc.M202575200.
100. Yasuda S, Stevens RL, Terada T, Takeda M, Hashimoto T, Fukae J, et al. 2007. Defective expression of Ras guanyl nucleotide-releasing protein 1 in a subset of patients with systemic lupus erythematosus. J Immunol 179:4890-900.
101. Zahedi B, Goo HJ, Beaulieu N, Tazmini G, Kay RJ, Cornell RB, et al. 2011. Phosphoinositide 3-kinase regulates plasma membrane targeting of the Ras-specific exchange factor RasGRP1. J Biol Chem 286:12712-23. doi: 10.1074/jbc.M110.189605.
102. Zhang G, Kazanietz MG, Blumberg PM, Hurley JH. 1995. Crystal structure of the cys2 activator-binding domain of protein kinase C delta in complex with phorbol ester. Cell 81:917-24. doi: 10.1016/0092-8674(95)90011-X.
103. Zhang M, Tanaka T, Ikura M. 1995. Calcium-induced conformational transition revealed by the solution structure of apo calmodulin. Nat Struct Biol 2:758-67. doi: 10.1038/nsb0995-758.
104. Zhu M, Fuller DM, Zhang W. 2012. The role of Ras guanine nucleotide releasing protein 4 in Fc epsilonRI-mediated signaling, mast cell function, and T cell development. J Biol Chem 287:8135-43. doi: 10.1074/jbc.M111.320580.
105. Zweckstetter M, Bax A. 2000. Prediction of sterically induced alignment in a dilute liquid crystalline phase: aid to protein structure determination by NMR. J Am Chem Soc 122:3791-2. doi: 10.1021/ja0000908.